Quick Answer
Ocugen, Inc. reported Revenue (ASC 606) of $4.41 million for fiscal year 2025.
Ocugen, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $4.41M | +8.8% |
| 2024 | $4.05M | -32.8% |
| 2023 | $6.04M | +142.6% |
| 2022 | $2.49M | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.75M | +54.2% | +27.6% |
| June 30, 2025 | $1.37M | +20.3% | -7.3% |
| March 31, 2025 | $1.48M | +46.1% | +30.4% |
| September 30, 2024 | $1.14M | -69.3% | -0.4% |
| June 30, 2024 | $1.14M | +135.3% | +12.5% |
| March 31, 2024 | $1.01M | +128.9% | -72.6% |
| September 30, 2023 | $3.70M | — | +662.7% |
| June 30, 2023 | $485.0K | — | +9.5% |
- Ocugen, Inc. showed an increase of +8.8% in Revenue (ASC 606) compared to the prior fiscal year.
- The most recent figure is from Ocugen, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: